Ready to expand, GenScript raises $224M for CDMO focused on antibodies, cell and gene therapies
China’s GenScript has brought in new investors to back its biologics-focused subsidiary — to the tune of $224 million.
GenScript, which is listed in Hong Kong …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
